Search

Your search keyword '"Camastra S"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Camastra S" Remove constraint Author: "Camastra S" Search Limiters Full Text Remove constraint Search Limiters: Full Text
95 results on '"Camastra S"'

Search Results

8. Insulin action and non-esterified fatty acids

12. Insulin resistance in morbid obesity: Reversal with intramyocellular fat depletion

19. beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss.

21. Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man.

22. 35th Annual Meeting of the European Association for the Study of Diabetes

24. Insulin action and non-esterified fatty acids

25. Expression of thyrotropin and thyroid hormone receptors in the adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.

27. Both 3,5-diiodo-L-thyronine (T2) and T3 modulate glucose-induced insulin secretion

28. Position statement of Italian Society of Obesity (SIO): Gestational Obesity.

29. Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway.

30. Nutrients handling after bariatric surgery, the role of gastrointestinal adaptation.

31. Cytokines as Targets of Novel Therapies for Graves' Ophthalmopathy.

32. Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies.

33. microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function.

34. Publisher Correction: Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery.

35. Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery.

36. Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion.

37. Decreased expression of hepatic glucokinase in type 2 diabetes.

38. Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids.

39. Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients.

40. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance.

41. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.

42. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.

43. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.

44. beta-cell function in obesity: effects of weight loss.

45. Effect of acute hyperglycemia on insulin secretion in humans.

46. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion.

47. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss.

48. Insulin prolongs the QTc interval in humans.

49. Effect of vitamin C on forearm blood flow and glucose metabolism in essential hypertension.

50. Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach.

Catalog

Books, media, physical & digital resources